Kamran Kadkhoda

Dr. Kamran Kadkhoda

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 January 2021 in American Journal of Clinical Pathology
Verified
Journal Article
Closed access
KKKamran Kadkhoda
Kamran Kadkhoda

29 April 2020 in mSphere
Verified
Journal Article
Open access
PDF file
KKKamran Kadkhoda
Kamran Kadkhoda
Since its emergence in December 2019, it took only a couple of months for an outbreak of the novel coronavirus disease 2019 (COVID-19) to be declared a pandemic by the World Health Organization (WHO). This along with the highly infectious nature of the disease and the associated mortality call for particular attention to the underlying (immuno)pathomechanism(s). The latter will inform case management and vaccine design. Unravelling these mechanisms can assist basic scientists, laboratory medicine practitioners, clinicians, public health practitioners, funding agencies, and health care policymakers in responding to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic.

8 November 2020 in Journal of Dietary Supplements
Verified
Journal Article
Closed access
SNSreus A. G. Naidu
Sreus A. G. Naidu
RCRoger Clemens
Roger Clemens
PPPeter Pressman
Peter Pressman
MZMehreen Zaigham
Mehreen Zaigham
KKKamran Kadkhoda
Kamran Kadkhoda
ANA. Satyanarayan Naidu
A. Satyanarayan Naidu
Coronavirus Disease 2019 (COVID-19) triggered by Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) infection has been declared a pandemic by the World Health Organization (WHO) on March 11, 2020. Oxidative stress and its related metabolic syndromes are potential risk factors in the susceptibility to, and severity of COVID-19. In concert with the earliest reports of COVID-19, obstetricians started to diagnose and treat SARS-CoV-2 infections during pregnancy (“COVID-19-Pregnancy”). High metabolic demand to sustain normal fetal development increases the burden of oxidative stress in pregnancy. Intracellular redox changes intertwined with acute phase responses at the maternal-fetal interface could amplify during pregnancy. Interestingly, mother-to-fetus transmission of SARS-CoV-2 has not been detected in most of the COVID-19-Pregnancy cases. This relative absence of vertical transmission may be related to the presence of lactoferrin in the placenta, amniotic fluid, and lacteal secretions. However, the cytokine-storm induced during COVID-19-Pregnancy may cause severe inflammatory damage to the fetus, and if uncontrolled, may later result in autism spectrum-like disorders and brain development abnormalities in neonates. Considering this serious health threat to child growth and development, the prevention of COVID-19 during pregnancy should be considered a high priority. This review summarizes the intricate virulence factors of COVID-19 and elucidate its pathobiological spectrum during pregnancy and postpartum periods with a focus on the putative and complex roles of endogenous and exogenous lactoferrin in conferring immunological advantage to the host.

26 April 2021 in Journal of Thrombosis and Haemostasis
Verified
Journal Article
Closed access
PDF file
KKKamran Kadkhoda
Kamran Kadkhoda

9 December 2021 in Vaccine
Verified
Journal Article
Closed access
KKKamran Kadkhoda
Kamran Kadkhoda

1 July 2020 in Transfusion
Verified
Journal Article
Closed access
PDF file
KKKamran Kadkhoda
Kamran Kadkhoda